• Next meeting: GBM #17

  Apr 19, 2024

  The next SySTEAM general body meeting (GBM) will be held on Thursday, September 12, 2024, at 10AM Eastern.

• Test

  Mar 24, 2024

• INCOSE Certification Cohort

  Mar 23, 2024

• Introduction to CSRM

  Oct 27, 2023

  test post

• Does my reference have to be a SEP?

  May 26, 2023

  References must know what SE is, but they don't have to be systems engineers.

Risk Management Working Group: A General Method to Objectively Perform Risk-Benefit Analysis

Jan 16, 2024 2:00 PM - 3:30 PM Eastern Standard Time

Topic: A General Method to Objectively Perform Risk-Benefit Analysis
Speaker(s): Richard Matt
Date: Tuesday, 16 January 2024
Time:  2:00 PM - 3:30 PM Eastern Time Zone
Location: Virtual via Zoom
https://incose-org.zoom.us/meeting/register/tZwpcOmrqTgoGND_l4eqrIYqNNJpnFyCdrdm#/registration

Click here to download flyer: Risk Management Working Group: A General Method to Objectively Perform Risk-Benefit Analysis

Meeting Description:
Ever since the phrase “First, do no harm” was coined, the requirement that the benefits of a medical procedure outweigh its risks has been central to medicine. In addition to regulators’ universal requirement that a manufacturer show their product’s benefits exceed its risks before allowing product sales, ‘benefit exceeds risk’ is also central to product availability, documentation compliance, and enforcement decisions. Despite the central importance of benefit-risk analysis, most analyses today present benefits and risks as unrelated facts (even in FDA guidance publications), making comparison difficult and the defense of conclusions as to which is bigger easy to challenge. This presentation shows a novel, systematic approach to benefit-risk analysis. The approach’s cornerstone is to use the same metric to measure both benefit and risk. Measuring both benefit and risk with the same metric makes comparisons of the amount of benefit and risk straightforward and intuitive – leading to conclusions that are significantly more objective and defensible.

Want to know more about the Risk Management Working Group? Visit: https://www.incose.org/communities/working-groups-initiatives/risk-management

Risk Management Working Group: A General Method to Objectively Perform Risk-Benefit Analysis

Jan 16, 2024 2:00 PM - 3:30 PM Eastern Standard Time

Topic: A General Method to Objectively Perform Risk-Benefit Analysis
Speaker(s): Richard Matt
Date: Tuesday, 16 January 2024
Time:  2:00 PM - 3:30 PM Eastern Time Zone
Location: Virtual via Zoom
https://incose-org.zoom.us/meeting/register/tZwpcOmrqTgoGND_l4eqrIYqNNJpnFyCdrdm#/registration

Click here to download flyer: Risk Management Working Group: A General Method to Objectively Perform Risk-Benefit Analysis

Meeting Description:
Ever since the phrase “First, do no harm” was coined, the requirement that the benefits of a medical procedure outweigh its risks has been central to medicine. In addition to regulators’ universal requirement that a manufacturer show their product’s benefits exceed its risks before allowing product sales, ‘benefit exceeds risk’ is also central to product availability, documentation compliance, and enforcement decisions. Despite the central importance of benefit-risk analysis, most analyses today present benefits and risks as unrelated facts (even in FDA guidance publications), making comparison difficult and the defense of conclusions as to which is bigger easy to challenge. This presentation shows a novel, systematic approach to benefit-risk analysis. The approach’s cornerstone is to use the same metric to measure both benefit and risk. Measuring both benefit and risk with the same metric makes comparisons of the amount of benefit and risk straightforward and intuitive – leading to conclusions that are significantly more objective and defensible.

Want to know more about the Risk Management Working Group? Visit: https://www.incose.org/communities/working-groups-initiatives/risk-management

Risk Management Working Group: A General Method to Objectively Perform Risk-Benefit Analysis

16 January, 2024, 11 AM-12 30 PM

Topic: A General Method to Objectively Perform Risk-Benefit Analysis
Speaker(s): Richard Matt
Date: Tuesday, 16 January 2024
Time:  2:00 PM - 3:30 PM Eastern Time Zone
Location: Virtual via Zoom
https://incose-org.zoom.us/meeting/register/tZwpcOmrqTgoGND_l4eqrIYqNNJpnFyCdrdm#/registration

Click here to download flyer: Risk Management Working Group: A General Method to Objectively Perform Risk-Benefit Analysis

Meeting Description:
Ever since the phrase “First, do no harm” was coined, the requirement that the benefits of a medical procedure outweigh its risks has been central to medicine. In addition to regulators’ universal requirement that a manufacturer show their product’s benefits exceed its risks before allowing product sales, ‘benefit exceeds risk’ is also central to product availability, documentation compliance, and enforcement decisions. Despite the central importance of benefit-risk analysis, most analyses today present benefits and risks as unrelated facts (even in FDA guidance publications), making comparison difficult and the defense of conclusions as to which is bigger easy to challenge. This presentation shows a novel, systematic approach to benefit-risk analysis. The approach’s cornerstone is to use the same metric to measure both benefit and risk. Measuring both benefit and risk with the same metric makes comparisons of the amount of benefit and risk straightforward and intuitive – leading to conclusions that are significantly more objective and defensible.

Want to know more about the Risk Management Working Group? Visit: https://www.incose.org/communities/working-groups-initiatives/risk-management

• INCOSE Recognizes Georgia Tech Master’s Programs for Academic Equivalency

  Jun 11, 2024

• New Academic Equivalency Agreement with George Washington University

  Jun 11, 2024

• Space Coast Chapter Officers & Board of Directors for 2024

  Feb 04, 2024

• Student Division (SDiv) Awards 2024

  Feb 01, 2024

• Press Release: Guide to SysML Model of a "Smart Parking Lot" is Published

  Dec 19, 2023